Evidence and Resources

The best outcomes start with evidence. And when evidence underpins policies and programs and is shared across borders and sectors, it can drive radical progress.

Explore the latest resources on multiple micronutrient supplements (MMS) research, policy, and implementation below.

ImplementationManufacturersProduct Specifications
UNIMMAP MMS Product Packaging Options, Cost, and Environmental Impact
Kirk HumanitarianSeptember 2023
Infographic presenting the financial and environmental implications and availability of MMS depending on common packaging options.
Manufacturers
Kirk Humanitarian announces new manufacturing agreement with Dexa Medica Pharmaceutical
March 2023
Partnership will bring high-impact prenatal vitamins and minerals to women in need across Southeast AsiaU.S.-based family foundation Kirk Humanitarian today an…
Manufacturers
Contract Pharmacal Corp (CPC)
CPCSeptember 2019
Contract pharmaceutical manufacturer and developer in the U.S. known to manufacture MMS.
Manufacturers
Lomapharm
Lomapharm August 2019
Contract pharmaceutical manufacturer and developer in Germany known to manufacture MMS.

After 20 years of research and some 20 studies and meta-analyses comparing IFA and MMS on birth outcomes, it is unethical to further withhold MMS from pregnant women in low-resource settings.”

Klaus Kraemer, PhD, Sight and Life

Learn more about our work and impact.

Learn about recommended MMS technical specifications.

Evidence and Resources

UNIMMAP MMS Product Packaging Options, Cost, and Environmental Impact

Kirk Humanitarian announces new manufacturing agreement with Dexa Medica Pharmaceutical

Contract Pharmacal Corp (CPC)

Lomapharm

Klaus Kraemer, PhD, Sight and Life